| Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx MA Carden, M Gaddh, A Hoskote, M Brown, V Merrill, SR Stowell, ... Blood Advances 4 (3), 477-481, 2020 | 10 | 2020 |
| Trends and In-Hospital outcomes of splanchnic vein thrombosis associated with gastrointestinal malignancies: a nationwide analysis S Handa, K Gupta, M Sterpi, A Khan, A Hoskote, A Kasi Gastrointestinal Tumors 8 (2), 71-80, 2021 | 7 | 2021 |
| COMPARISON OF HIGHER VERSUS LOWER DOSE STEROID ADMINISTRATION IN PATIENTS WITH COVID-19 AND ACUTE HYPOXEMIC RESPIRATORY FAILURE ON INHALED EPOPROSTENOL MA Riego, O Mahmoud, N Garg, E T ROBIN, DJ Shah, EA Zipf, A Hoskote, ... Chest 162 (4), A911-A912, 2022 | | 2022 |
| Rituximab leads to early elimination of circulating CD20 (+) T and B lymphocytes in patients with iTTP despite ongoing TPEx (vol 4, pg 477, 2020) MA Carden, M Gaddh, A Hoskote BLOOD ADVANCES 4 (6), 1093-1093, 2020 | | 2020 |
| 585: A RARE CASE OF AUSTRIAN SYNDROME IN AN ELDERLY WOMAN S Rajeeve, B Sabharwal, P Kohli, A Hoskote, D Patadia, J Salonia Critical Care Medicine 48 (1), 273, 2020 | | 2020 |
| of circulating CD20 T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020; 4 (3): 477-481. MA Carden, M Gaddh, A Hoskote | | 2020 |
Shivani HandaIcahn School of Medicine/ Tisch Cancer InstituteVerified email at mountsinai.org
